Company Encyclopedia
View More
name
CLOUDBREAK-B
02592.HK
Cloudbreak Pharma Inc., a clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases. The company develops CBT-001, which is in Phase 3 clinical trial for treating pterygium; CBT-009, a topical formulation of atropine that is in Phase 1/2 study indicated for the treatment of juvenile myopia; CBT-004, a VEGF receptor inhibitor, which is in Phase 2 clinical trial for treating vascularised pinguecula; and CBT-006, a cholesterol dissolving molecule containing the active pharmaceutical ingredient of hydroxypropyl beta-cyclodextrins that is in Phase 2 clinical trial for the treatment of meibomian gland dysfunction associated dry eye disease. It also develops CBT-199 and CBT-145 for the treatment of presbyopia, a condition caused by an age-related process; CBT-007, an eye drop for enhancing success rate of glaucoma filtration surgery; and CBT-011, an antibody-drug-synergism conjugate for the treatment of diabetic macular edema. The company was founded in 2015 and is headquartered in Irvine, California.
1.338 T
02592.HKMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Top 10 HK Stock Losers (12.11)

    RS MACALLINE(01528) fell 14.39%, with a trading turnover 130.5 Million HKD, and a year-to-date fell 33.1%. QUNABOX GROUP(00917) fell 13.99%, with a trading turnover 120.0 Million HKD, and a year-to-date fell 61.8%. ZTE(00763) fell 13.08%, with a trading turnover 3.0 Billion HKD, and a year-to-date rose 16.1%.

    Top Gainers & Losers·
    HK
    01528
    -2.52%
    HK
    00917
    +8.17%
    HK
    00763
    +4.00%
    Top Gainers & Losers·
    HK
    01528
    -2.52%
    HK
    00917
    +8.17%
    HK
    00763
    +4.00%

    Hong Kong Stock Movement: CLOUDBREAK-B fell 15.3%, clinical trial meeting triggers market uncertainty

    CLOUDBREAK-B fell 15.30%; Innovent Biologics fell 0.06%, with a transaction volume of HKD 527 million; Rongchang Biologics rose 1.30%, with a transaction volume of HKD 471 million; CanSino Biologics rose 0.68%, with a transaction volume of HKD 460 million; BeiGene's market value reached HKD 292.3 billion

    HK Stock Movers Tracker·
    HK
    02592
    -1.13%
    HK Stock Movers Tracker·
    HK
    02592
    -1.13%

    Top 10 HK Stock Gainers (12.8)

    LEMO SERVICES(02539) rose 47.86%, with a trading turnover 35.7 Million HKD, and a year-to-date rose 112%. TIANYU SEMI(02658) rose 27.65%, with a trading turnover 126.8 Million HKD, and a year-to-date fell 10.9%. TANWAN(09890) rose 11.63%, with a trading turnover 134.3 Million HKD, and a year-to-date rose 98.6%.

    Top Gainers & Losers·
    HK
    02539
    -0.87%
    HK
    02658
    -0.74%
    HK
    09890
    +8.85%
    Top Gainers & Losers·
    HK
    02539
    -0.87%
    HK
    02658
    -0.74%
    HK
    09890
    +8.85%

    Hong Kong Stock Movement: CLOUDBREAK-B rises 10.25%, clinical trial progress and FDA meeting boost market confidence

    CLOUDBREAK-B rose 10.25%; Innovent Biologics fell 6.79%, with a transaction volume of HKD 4.198 billion; Rongchang Biologics fell 10.36%, with a transaction volume of HKD 996 million; CanSino Biologics rose 0.08%, with a transaction volume of HKD 691 million; BeiGene fell 2.47%, with a market value of HKD 297.5 billion

    HK Stock Movers Tracker·
    HK
    02592
    -1.13%
    HK Stock Movers Tracker·
    HK
    02592
    -1.13%

    Hong Kong stock movement: Dual benefits of patent approval and clinical progress, CLOUDBREAK-B rises 15.43%

    CLOUDBREAK-B rose 15.43%; Innovent Biologics fell 2.55%, with a transaction volume reaching HKD 700 million; CanSino Biologics fell 1.27%, with a transaction volume reaching HKD 462 million; BeiGene rose 0.59%, with a transaction volume reaching HKD 437 million; Kelun-Bio fell 0.09%, with a market capitalization reaching HKD 106.5 billion

    HK Stock Movers Tracker·
    HK
    02592
    -1.13%
    HK Stock Movers Tracker·
    HK
    02592
    -1.13%
    © 2025 Longbridge｜Disclaimer